Immunotech Biopharm Ltd (HKG:6978)
Hong Kong · Delayed Price · Currency is HKD 0.3950
-0.0250 (-5.95%)
Sep 21, 2026, 1:09 PM HKT
Immunotech Biopharm Market Cap
Immunotech Biopharm has a market cap or net worth of 259.35 million as of September 18, 2026. Its market cap has decreased by -89.43% in one year.
Market Cap
259.35M
Enterprise Value
648.51M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
ChartMarket Cap Chart
Since July 10, 2020, Immunotech Biopharm's market cap has decreased from 7.74B to 259.35M, a decrease of -96.65%. That is a compound annual growth rate of -42.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 259.35M | -85.67% |
| Dec 31, 2025 | 1.81B | 52.87% |
| Dec 31, 2024 | 1.18B | -54.00% |
| Dec 29, 2023 | 2.57B | 7.99% |
| Dec 30, 2022 | 2.38B | -72.51% |
| Dec 31, 2021 | 8.67B | 50.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| JW (Cayman) Therapeutics Co. | 892.97M |
| Wuhan YZY Biopharma | 639.70M |
| Brii Biosciences | 638.80M |
| 3D Medicines | 607.42M |
| B&K Corporation | 470.63M |
| Cutia Therapeutics | 436.04M |
| Uni-Bio Science Group | 435.90M |
| Transcenta Holding | 415.98M |